Commitments and Contingencies - Additional Information (Detail) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Oct. 31, 2026 |
Sep. 30, 2026 |
Mar. 31, 2026 |
Sep. 30, 2026 |
Sep. 30, 2026 |
Dec. 31, 2025 |
Mar. 31, 2009 |
|
| Other Commitments [Line Items] | |||||||
| Payment received for settlement agreement | $ 39,000,000 | ||||||
| Gain on litigation settlement | $ 38,026,000 | $ 38,026,000 | |||||
| Litigation loss | 0 | ||||||
| Litigation liabilities | $ 0 | 0 | 0 | ||||
| Sarepta Settlement Agreement [Member] | |||||||
| Other Commitments [Line Items] | |||||||
| Payment received for settlement agreement | 39,000,000 | ||||||
| Gain on litigation settlement | 38,000,000 | ||||||
| GlaxoSmithKline LLC [Member] | |||||||
| Other Commitments [Line Items] | |||||||
| Milestone payment obligation | $ 1,500,000 | ||||||
| Accrued expeses | $ 900,000 | $ 900,000 | $ 900,000 | $ 5,700,000 | |||
| GlaxoSmithKline LLC [Member] | GSK Settlement Agreement [Member] | |||||||
| Other Commitments [Line Items] | |||||||
| Payment of settlement amount | $ 10,000,000 | ||||||